Mixed

Epigenetic clocks, particularly those tuned to phenotypic age or mortality risk (e.g., GrimAge), are robust biomarkers for predicting biological aging and adverse health outcomes.

Epigenetic clocks offer a promising way to measure biological age, potentially identifying those aging faster than their chronological age. This could guide personalized interventions to slow aging, though clinical application is still emerging.